Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation

International Journal of Hematology

Volumn 70, Issue 3, 1999, Pages 193-199

  Takeshima, Minoru ^a   Takamatsu, Hideyuki ^a   Iida, Megumi ^a   Mochizuki, Yasuhiro ^b   Okumura, Hirokazu ^c   Yoshida, Takashi ^a  

^a TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

CD34+ cell positive selection; Immune reconstitution; Peripheral blood stem cell transplantation; Viral infection

Indexed keywords

CD34 ANTIGEN;

AGED; ARTICLE; AUTOTRANSPLANTATION; BLOOD DISEASE; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; STEM CELL MOBILIZATION; TIME; TREATMENT OUTCOME; VIRUS INFECTION;

AGED; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0033210144     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Coiffier B, Philip T, Burnett AK, Symann ML. Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol 1994;12:226-31.
2. Björkstrand B, Ljungman P, Bird JM, Samson D, Gahrton G. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 1995;15:367-71.
3. Pettengell R, Radford JA, Morgenstern GR, et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1996;14:586-92.
4. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994;83:3068-76.
5. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-40.
6. + cells to remove circulating tumor cells. Blood 1996;87:1625-34.
7. Shpall EJ, Jones RB, Bearman SI, et al.Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
8. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-7.
9. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996;88:4132-8.
10. Yabe H, Yabe M, Hattori T, et at Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors. Bone Marrow Transplant 1996;17:985-91.
11. Pirsch JD, Maki DG. Infectious complication in adults with bone marrow transplantation and T cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann Intern Med 1986;104:619-31.
12. + cells from HLA-mismatched donors. Bone Marrow Transplant 1998;21:355-60.
13. Nagafuji K, Eto T, Hayashi S, Tokunaga Y, Gondo H, Niho Y. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998;21:301-3.
14. Sakuma H, Hosoya M, Kanno H, Kikuta A, Konno K, Kawano Y. Risk of cytomegalovirus infection after peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19:49-53.
15. + cells from blood. J Hematother 1993;2:247-50.
16. Makino S, Harada M, Akashi K, et al. A simplified method for cryopreservation of peripheral blood stem cells at -80°C without rate-controlled freezing. Bone Marrow Transplant 1991;8:239-44.
17. Gondo H, Minematsu T, Harada M, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Brit J Haematol 1994;86:130-7.
18. Henon PR, Liang H, Beck-Wirth G, et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992;9:285-91.
19. Roberts MM, To LB, Gillis D, et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993;12:469-75.
20. Takaue Y, Okamoto Y, Kawano Y, et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994;14:219-23.
21. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease. J Infec Dis 1992;165:352-63.
22. + selected vs. unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 1999;93:1858-68.
23. + marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992;80:1693-701.
24. +-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience. Bone Marrow Transplant 1997;20:827-34.